Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 400 of 701 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/30/09
End: 09/30/12
Due: 09/30/13
Phase: N/A
Priority: Normal
Start: 07/10/21
End: 12/02/21
Due: 12/02/22
Phase: N/A
Priority: Normal
Start: 08/25/24
End: 01/31/26
Due: 01/31/27
Phase: N/A
Priority: Normal
Start: 05/01/25
End: 11/30/27
Due: 11/30/28
Phase: N/A
Priority: Normal
Start: 03/31/15
End: 04/30/16
Due: 04/30/17
Phase: N/A
Priority: Normal
Start: 04/08/25
End: 06/30/26
Due: 06/30/27
Phase: N/A
Priority: Normal
Start: 03/31/16
End: 07/17/18
Due: 07/17/19
Phase: N/A
Priority: Normal
Start: 06/30/09
End: 02/28/13
Due: 02/28/14
Phase: N/A
Priority: Normal
Start: 01/13/22
End: 03/13/23
Due: 03/13/24
Phase: N/A
Priority: Normal
Start: 01/30/25
End: 10/31/25
Due: 10/31/26
Phase: N/A
Priority: Normal
Start: 06/30/12
End: 09/30/16
Due: 09/30/17
Phase: N/A
Priority: Normal
Start: 02/18/21
End: 02/28/26
Due: 02/28/27
Phase: N/A
Priority: Normal
Start: 01/13/15
End: 01/31/28
Due: 01/31/29
Phase: N/A
Priority: Normal
Start: 09/30/08
End: 05/31/14
Due: 05/31/15
Pilot Study for the Evaluation of Intravitreal Infliximab in the Treatment of Diabetic Macular Edema
Phase: N/A
Priority: Normal
Start: 08/31/09
End: 08/31/11
Due: 08/31/12
Phase: N/A
Priority: Normal
Start: 03/31/09
End: 09/30/12
Due: 09/30/13
Phase: N/A
Priority: Normal
Start: 01/19/17
End: 05/30/19
Due: 05/30/20
Phase: N/A
Priority: Normal
Start: 02/15/19
End: 04/01/22
Due: 04/01/23
Phase: N/A
Priority: Normal
Start: 06/30/09
End: 06/30/12
Due: 06/30/13
Phase: N/A
Priority: Normal
Start: 11/16/21
End: 06/30/25
Due: 06/30/26
Phase: N/A
Priority: Normal
Start: 10/03/19
End: 08/30/21
Due: 08/30/22
Phase: N/A
Priority: Normal
Start: 03/19/21
End: 07/02/21
Due: 07/02/22
Phase: N/A
Priority: Normal
Start: 04/05/19
End: 03/31/25
Due: 03/31/26
Phase: N/A
Priority: Normal
Start: 01/31/25
End: 05/31/25
Due: 05/31/26
Phase: N/A
Priority: Normal
Start: 06/21/20
End: 06/30/25
Due: 06/30/26